-
2015
Founded in 2015, Valgen Medtech Co., Ltd. established its headquarters in Hangzhou High-Tech Zone (Binjiang) Hangzhou and set up an R&D center in Shenzhen. The company's office and manufacturing site cover a floor space of nearly 10,000 square meters.
-
600+
Valgen Medtech specializes in the collaboration between hospitals and medical device manufacturers to provide integrated interventional treatment solutions to patients with bicuspid and tricuspid diseases. Valgen has applied for more than 600 patents worldwide for fundamental principles, core solutions, and/or key innovations of its products of which 200 of the patents have been granted.
-
280+
Valgen Medtech has employed more than 280 researchers, medical specialists, technicians, and manufacturing workers throughout China, nearly 20% of which are high-end talents with master's or doctoral degrees.
-
5+
Four of its products have passed NMPA's special review for innovative medical devices, and five of its products have been officially marketed.
Solutions
Valgen Medtech's core product, DragonFly™ Transcatheter Mitral Valve Repair System, is the first Chinese proprietary transfemoral transcatheter edge-to-edge mitral valve repair device approved by the NMPA.
Applicable to a wide range of anatomies, it is easy to operate for safe, controllable, and precise clipping.Its innovative design provides a safer and more effective solution for surgical high-risk senile patients; moreover, it requires significantly shorter postoperative hospital stays and rehabilitation times and offers a superior treatment option for patients with mitral regurgitation.
A green shield that protects doctors from intraoperative X ray irradiation during interventional ultrasonographic procedures in the catheterization room.
A non-compliant balloon dilatation catheter suitable for native valve dilation of cardio-aortic aortic valves.
For creating access to the left heart via transfemoral vein transseptal puncture into the left atrium.
Suitable for cardiovascular (coronary exclusive) interventional diagnostics and treatment procedures, especially interventional procedures for delivery devices into blood vessels, and positioning/establishing access to blood vessels.
Four clip sizes
Independent grasping
Readable indicators and rotary knobs
Central filler
Adjustable clipping angle
Unique catheter design
Innovative R&D
Abiding by the scientific philosophy of "Collaborations of Industry, Academia, Research, and Application", Valgen Medtech always gives priority to saving the lives of patients and improving the quality of life of patients in its constant exploration of the improvement of new technology and new applications and sharpening of the industry's core competitive edge to provide technology support to Chinese innovative medical devices.
-
Artificial chordae tendineae implantation system with position detection device
-
Artificial chordae tendineae implantation system with negative pressure device
-
Artificial chordae tendineae implantation system with auxiliary clipping device
-
A lockpin and interventional remote suture locking device for locking and tightening of sutures
-
Valve clipping devices and valve clipping systems
-
A heart valve prosthesis and its stent, and heart valve prosthesis replacement system
-
Absorbable suture system
-
An atrioventricular valve clipping device and atrioventricular valve clipping system
-
Zhejiang Technology-oriented Small- and Medium-sized Enterprise Certificate
Patient Care
News and Information
Providing doctors and patients with more innovative technology-based minimally-invasive interventional treatment solutions
-
2023-12-13
Breakthrough｜Valgen Medtech's Transcatheter Hypertrophic Cardiomyopathy (HCM) Ablation Technique Successfully Used for Exploratory Clinical Application in 10 Patients
A team led by Profession Fang Zhenfei at the Second Xiangya Hospital of Central South University has once again applied the DragonFire myocardium RF ablation system and the transcatheter cardiomyopathy RF ablation needle and its guiding system……
Read More
-
2023-11-30
Big News｜Valgen DragonFly™ Transcatheter Mitral Valve Repair System Granted Marketing Approval in China by the NMPA
November 29, 2023 - Hangzhou Valgen Medtech Co., Ltd. (Valgen Medtech) announced that its in-house developed DragonFly™ Transcatheter Mitral Valve Repair System (DragonFly™) has been granted marketing approval by the National Medical Products Administrati
Read More
-
2023-11-22
Valgen Medtech and Venus Medtech reached a consensus on signing a letter of intent for exclusive cooperation on strategic marketing to speed up the promotion of techniques for diagnosis and treatment of valvular heart disease (VHD) in China
November 22, 2023 -- Venus MedTech (Hangzhou) Inc. (Venus Medtech) and Hangzhou Valgen Medtech Co., Ltd. (Valgen Medtech) reached a consensus on signing a letter of intent for exclusive cooperation on strategic marketing for the Valgen Medtech DragonFly™
Read More
